Floatz logo

Therapeutic Asset Ratings

368 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Telisotuzumab Adizutecan
Pancreatic Neoplasm
AbbVieP1C (36)
Tgfβ-B-15 Peptide
Pancreatic Neoplasm
Inna Chen, MDP1C (36)
TTI 101
Pancreatic Neoplasm
Washington University School of MedicineP1C (36)
u87 car-t
Pancreatic Neoplasm
Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdP1C (36)
Ucmym802
Pancreatic Neoplasm
UTC Therapeutics Inc.P1C (36)
Ulixertinib
Pancreatic Neoplasm
UNC Lineberger Comprehensive Cancer CenterP1C (36)
Vcn-01
Pancreatic Neoplasm
University of PennsylvaniaP1C (36)
Wm-A1-3389
Pancreatic Neoplasm
Wellmarker BioP1C (36)
Zabadinostat
Pancreatic Neoplasm
ImmunityBio, Inc.P1C (36)
Zn-C3
Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1C (36)
Zunsemetinib
Pancreatic Neoplasm
Washington University School of MedicineP1C (36)
(3RS)-1-(6-(.ALPHA.-METHYLPOLY(OXYETHYLENE)AMINO)-6-OXOHEXYL)-2,5-DIOXOPYRROLIDIN-3-YL)-L-CYSTEINAMIDE, (20000 MW)
Pancreatic Neoplasm
Lumicell, Inc.P1/2C (36)
Tamibarotene
Pancreatic Neoplasm
Nagoya UniversityP1/2C (36)
msc1936369b
Pancreatic Cancer
Day One Biopharmaceuticals, Inc.P1C (34)
177lu-ctr-fapi
Pancreatic Neoplasm
Yan XingEarly P1C (33)
[177Lu]Lu-HT547
Pancreatic Neoplasm
Hua PangEarly P1C (33)
[⁶⁸Ga]Ga-HT547
Pancreatic Neoplasm
Hua PangEarly P1C (33)
68Ga-NODAGA-SNA006
Pancreatic Neoplasm
SmartNuclide BiopharmaEarly P1C (33)
Anti-Ex02 Car T Cells
Pancreatic Neoplasm
Zhang Xiaofeng,MDEarly P1C (33)
Benadryl
Pancreatic Cancer
Zhang Xiaofeng,MDEarly P1C (33)
Cobalamin
Pancreatic Cancer
University of Illinois at ChicagoEarly P1C (33)
es502
Pancreatic Neoplasm
Ruijin HospitalEarly P1C (33)
Evolocumab
Pancreatic Cancer
CHU de Quebec-Universite LavalEarly P1C (33)
Ezetimibe
Pancreatic Cancer
CHU de Quebec-Universite LavalEarly P1C (33)
[Ga-68]MTP220
Pancreatic Neoplasm
Qiubai LiEarly P1C (33)
Showing 301 to 325 of 368 assets
PreviousPage 13 of 15Next